vs
Digimarc CORP（DMRC）与NEPHROS INC（NEPH）财务数据对比。点击上方公司名可切换其他公司
Digimarc CORP的季度营收约是NEPHROS INC的1.9倍（$8.9M vs $4.7M），NEPHROS INC净利率更高（1.3% vs -47.2%，领先48.5%），NEPHROS INC同比增速更快（22.2% vs 2.9%），过去两年NEPHROS INC的营收复合增速更高（15.9% vs -5.3%）
迪吉马克公司是一家企业软件与服务提供商，其主打产品包含带数字标识符的软件，主要用于解决防伪问题、验证产品真伪、提升回收准确性以及实现供应链可追溯，产品可广泛应用于服装、快消品、美妆健康、汽车等多个行业领域。
Nephros Inc是一家医疗科技企业，主要研发和销售高性能净水系统、感染防控产品及肾脏护理解决方案，产品主要供给北美地区的医院、透析诊所以及长期护理机构，用于降低水传播病原体风险，提升患者诊疗效果。
DMRC vs NEPH — 直观对比
营收规模更大
DMRC
是对方的1.9倍
$4.7M
营收增速更快
NEPH
高出19.3%
2.9%
净利率更高
NEPH
高出48.5%
-47.2%
两年增速更快
NEPH
近两年复合增速
-5.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $8.9M | $4.7M |
| 净利润 | $-4.2M | $62.0K |
| 毛利率 | 63.5% | 58.4% |
| 营业利润率 | -48.2% | 0.4% |
| 净利率 | -47.2% | 1.3% |
| 营收同比 | 2.9% | 22.2% |
| 净利润同比 | 51.4% | -82.2% |
| 每股收益（稀释后） | $-0.18 | $0.01 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DMRCNEPH
| Q4 25 | $8.9M | $4.7M | ||
| Q3 25 | $7.6M | $4.8M | ||
| Q2 25 | $8.0M | $4.4M | ||
| Q1 25 | $9.4M | $4.9M | ||
| Q4 24 | $8.7M | $3.9M | ||
| Q3 24 | $9.4M | $3.5M | ||
| Q2 24 | $10.4M | $3.3M | ||
| Q1 24 | $9.9M | $3.5M |
净利润DMRCNEPH
| Q4 25 | $-4.2M | $62.0K | ||
| Q3 25 | $-8.2M | $337.0K | ||
| Q2 25 | $-8.2M | $237.0K | ||
| Q1 25 | $-11.7M | $558.0K | ||
| Q4 24 | $-8.6M | $349.0K | ||
| Q3 24 | $-10.8M | $183.0K | ||
| Q2 24 | $-9.3M | $-289.0K | ||
| Q1 24 | $-10.3M | $-169.0K |
毛利率DMRCNEPH
| Q4 25 | 63.5% | 58.4% | ||
| Q3 25 | 58.3% | 61.2% | ||
| Q2 25 | 58.8% | 63.2% | ||
| Q1 25 | 65.0% | 64.7% | ||
| Q4 24 | 60.8% | 64.0% | ||
| Q3 24 | 62.4% | 61.1% | ||
| Q2 24 | 66.1% | 58.8% | ||
| Q1 24 | 62.5% | 62.1% |
营业利润率DMRCNEPH
| Q4 25 | -48.2% | 0.4% | ||
| Q3 25 | -109.7% | 6.6% | ||
| Q2 25 | -105.2% | 5.6% | ||
| Q1 25 | -128.9% | 11.6% | ||
| Q4 24 | -105.1% | 8.2% | ||
| Q3 24 | -120.4% | 5.9% | ||
| Q2 24 | -96.2% | -9.7% | ||
| Q1 24 | -109.2% | -5.7% |
净利率DMRCNEPH
| Q4 25 | -47.2% | 1.3% | ||
| Q3 25 | -106.9% | 7.1% | ||
| Q2 25 | -102.6% | 5.4% | ||
| Q1 25 | -125.2% | 11.4% | ||
| Q4 24 | -99.9% | 9.0% | ||
| Q3 24 | -113.9% | 5.2% | ||
| Q2 24 | -89.3% | -8.9% | ||
| Q1 24 | -104.0% | -4.8% |
每股收益（稀释后）DMRCNEPH
| Q4 25 | $-0.18 | $0.01 | ||
| Q3 25 | $-0.38 | $0.03 | ||
| Q2 25 | $-0.38 | $0.02 | ||
| Q1 25 | $-0.55 | $0.05 | ||
| Q4 24 | $-0.40 | $0.04 | ||
| Q3 24 | $-0.50 | $0.02 | ||
| Q2 24 | $-0.43 | $-0.03 | ||
| Q1 24 | $-0.50 | $-0.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $12.9M | $5.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $40.2M | $10.2M |
| 总资产 | $53.0M | $13.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DMRCNEPH
| Q4 25 | $12.9M | $5.4M | ||
| Q3 25 | $12.6M | $5.2M | ||
| Q2 25 | $16.1M | $5.1M | ||
| Q1 25 | $21.6M | $4.1M | ||
| Q4 24 | $28.7M | $3.8M | ||
| Q3 24 | $33.7M | $2.5M | ||
| Q2 24 | $41.5M | $3.1M | ||
| Q1 24 | $48.9M | $3.6M |
股东权益DMRCNEPH
| Q4 25 | $40.2M | $10.2M | ||
| Q3 25 | $41.4M | $10.0M | ||
| Q2 25 | $46.5M | $9.6M | ||
| Q1 25 | $50.0M | $9.3M | ||
| Q4 24 | $61.4M | $8.6M | ||
| Q3 24 | $70.2M | $8.2M | ||
| Q2 24 | $77.2M | $7.9M | ||
| Q1 24 | $84.5M | $8.2M |
总资产DMRCNEPH
| Q4 25 | $53.0M | $13.6M | ||
| Q3 25 | $55.4M | $13.2M | ||
| Q2 25 | $60.7M | $12.2M | ||
| Q1 25 | $66.5M | $11.8M | ||
| Q4 24 | $75.8M | $11.2M | ||
| Q3 24 | $85.0M | $10.4M | ||
| Q2 24 | $93.4M | $11.1M | ||
| Q1 24 | $99.7M | $11.4M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $991.0K | $230.0K |
| 自由现金流经营现金流 - 资本支出 | $895.0K | — |
| 自由现金流率自由现金流/营收 | 10.0% | — |
| 资本支出强度资本支出/营收 | 1.1% | — |
| 现金转化率经营现金流/净利润 | — | 3.71× |
| 过去12个月自由现金流最近4个季度 | $-12.3M | — |
8季度趋势，按日历期对齐
经营现金流DMRCNEPH
| Q4 25 | $991.0K | $230.0K | ||
| Q3 25 | $-2.6M | $99.0K | ||
| Q2 25 | $-4.7M | $994.0K | ||
| Q1 25 | $-5.5M | $322.0K | ||
| Q4 24 | $-4.2M | $1.3M | ||
| Q3 24 | $-7.1M | $-623.0K | ||
| Q2 24 | $-6.8M | $-501.0K | ||
| Q1 24 | $-8.4M | $-672.0K |
自由现金流DMRCNEPH
| Q4 25 | $895.0K | — | ||
| Q3 25 | $-2.8M | — | ||
| Q2 25 | $-4.9M | — | ||
| Q1 25 | $-5.5M | — | ||
| Q4 24 | $-4.2M | — | ||
| Q3 24 | $-7.2M | — | ||
| Q2 24 | $-6.9M | — | ||
| Q1 24 | $-8.5M | — |
自由现金流率DMRCNEPH
| Q4 25 | 10.0% | — | ||
| Q3 25 | -36.9% | — | ||
| Q2 25 | -61.0% | — | ||
| Q1 25 | -59.1% | — | ||
| Q4 24 | -49.1% | — | ||
| Q3 24 | -75.7% | — | ||
| Q2 24 | -66.1% | — | ||
| Q1 24 | -85.8% | — |
资本支出强度DMRCNEPH
| Q4 25 | 1.1% | — | ||
| Q3 25 | 2.9% | — | ||
| Q2 25 | 2.5% | — | ||
| Q1 25 | 0.6% | — | ||
| Q4 24 | 0.2% | — | ||
| Q3 24 | 0.7% | 0.0% | ||
| Q2 24 | 0.3% | — | ||
| Q1 24 | 1.1% | — |
现金转化率DMRCNEPH
| Q4 25 | — | 3.71× | ||
| Q3 25 | — | 0.29× | ||
| Q2 25 | — | 4.19× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 3.74× | ||
| Q3 24 | — | -3.40× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DMRC
| Subscription | $5.3M | 60% |
| The Government | $3.6M | 41% |
NEPH
| Products | $4.6M | 98% |
| Other | $108.0K | 2% |
